73 related articles for article (PubMed ID: 6968594)
1. Low-molecular weight immunomodulators produced by microorganisms.
Umezawa H
Biotechnol Bioeng; 1980; 22 Suppl 1():99-110. PubMed ID: 6968594
[No Abstract] [Full Text] [Related]
2. Low-molecular-weight immunomodifiers produced by micro-organisms.
Umezawa H
Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
[No Abstract] [Full Text] [Related]
3. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
4. [Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
Lin ZB; Shi JP
Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):115-20. PubMed ID: 3892667
[No Abstract] [Full Text] [Related]
5. Isolation, characterization and biological evaluation of datura lactones as potential immunomodulators.
Bhat BA; Dhar KL; Puri SC; Qurishi MA; Khajuria A; Gupta A; Qazi GN
Bioorg Med Chem; 2005 Dec; 13(24):6672-7. PubMed ID: 16198115
[TBL] [Abstract][Full Text] [Related]
6. Effects of enzyme inhibitors in inhibiting the growth and inducing the differentiation of human promyelocytic leukemia cells, HL-60.
Miura K; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 May; 39(5):734-5. PubMed ID: 3460977
[No Abstract] [Full Text] [Related]
7. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
8. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
Umezawa H
Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight immunomodifiers produced by microorganisms.
Umezawa H; Ishizuka M
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
[TBL] [Abstract][Full Text] [Related]
10. [Low-molecular-weight immunocorrectors of natural origin].
Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
[No Abstract] [Full Text] [Related]
11. In vivo actions of bestatin-related compounds in relation to their actions in vitro.
Aoyagi T; Wada T; Ohuchi S; Kawamura K; Fukatsu S; Umezawa H
Biochem Int; 1984 Nov; 9(5):643-50. PubMed ID: 6525200
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
Millership JJ; Didier ES; Okhuysen PC; Maddry JA; Kwong CD; Chen X; Snowden KF
J Eukaryot Microbiol; 2001; Suppl():95S-98S. PubMed ID: 11906096
[No Abstract] [Full Text] [Related]
13. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
[TBL] [Abstract][Full Text] [Related]
15. [Low-molecular weight immunomodulators of microbial origin].
Khurnova LM; Ivanitskaia LP
Antibiot Khimioter; 1989 Oct; 34(10):786-92. PubMed ID: 2694992
[No Abstract] [Full Text] [Related]
16. Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.
Lass C; Vocanson M; Wagner S; Schempp CM; Nicolas JF; Merfort I; Martin SF
Exp Dermatol; 2008 Oct; 17(10):849-57. PubMed ID: 18341569
[TBL] [Abstract][Full Text] [Related]
17. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
Bachelier A; Mayer R; Klein CD
Bioorg Med Chem Lett; 2006 Nov; 16(21):5605-9. PubMed ID: 16945528
[TBL] [Abstract][Full Text] [Related]
18. Suppression of splenic enzyme activities by administration of aminopeptidase N (CD13) inhibitors: relationship between actions in vivo and in vitro.
Kocha T; Ohtsuka E; Funahashi T; Fukuda T; Aoyagi T; Wanda T; Takeuchi T
J Enzyme Inhib; 1994; 8(3):187-95. PubMed ID: 7539487
[TBL] [Abstract][Full Text] [Related]
19. Tumor delayed hypersensitivity reactions. "In vivo" functional differences between spleen and peripheral blood lymphocytes.
de Bonaparte YP; Oisgold-Dagá S; Klein S; Stillitani-D'Elia I
Biomedicine; 1980 Feb; 33(1):16-8. PubMed ID: 7370382
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa.
Máñez S; Hernández V; Giner RM; Ríos JL; Recio Mdel C
Fitoterapia; 2007 Jun; 78(4):329-31. PubMed ID: 17490829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
